PancellaPancella

Telephone

1-888-613-6862

Email Address

info@pancella.com

Office Address

1300-661 University Ave, Toronto

  • Home
  • About
    • Company Overview
      • Pluristyx
      • Implant Therapeutics
    • Management Team
    • Board of Directors
  • Technology
    • Origin
    • Core Technology
      • FailSafe®
    • Patents
    • Publications
  • Products & Licensing
    • Technology Licensing
  • News & Events
    • FAQ
    • Press Releases
CONTACT

Category Archives: Uncategorized

Pancella   →  Blog   →  Uncategorized

panCELLa One Cell To Save A Million Others

Author By Jake KrembilPosted on July 20, 2022
panCELLa is honoured to be recognized by Life Sciences Review and one of the Top 10 Biotech Companies in Canada.   https://www.lifesciencesreview.com/pancella...

panCELLa Inc. Announces Issuance of European Patent for Tools and Methods for Using Cell Division Loci to Control Proliferation of Cells

Author By Jake KrembilPosted on December 17, 2020October 19, 2021
panCELLa, a privately held biotechnology company focused on developing safe therapeutic cell products for a broad range of diseases, is pleased to announce the first issuance of the FailSafeTM patent in Europe.  This pa...
panCELLa aims to make our therapeutic cell-focused Platform Technologies widely available for the treatment of degenerative, infectious and malignant diseases.

Useful Links

  • Company Overview
  • Board of Directors
  • Management Team
  • Careers
  • Contact

OUR SERVICES

  • Origin
  • Patents
  • Publications
  • Products & Licensing
  • Press Releases

RECENT POSTS

  • Pluristyx and panCELLa Expand Intellectual Property Portfolio for Pluripotent Stem Cell Cloaking Technology January 18, 2023
  • Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement October 6, 2022
  • panCELLa One Cell To Save A Million Others July 20, 2022
Copyright © 2023 PanCELLa. All rights reserved.